Risk Characterization of Treatment Histories and Comorbidities Regarding Tuberculosis Treatment Status in West Sumatra Province 2020-2021
DOI:
https://doi.org/10.35730/jk.v14i3.988Keywords:
Karakterisasi Risiko, riwayat pengobatan, Komorbiditas, Status Pengobatan, TBC Risk Characterization, Treatment History, Comorbidity, Treatment Status, TBCAbstract
Background: Tuberculosis (TB) is the leading cause of death among bacterial infectious diseases worldwide, and Indonesia is the second country with the highest TB burden.
Objective: The treatment history and comorbidities of TB disease play a significant role in determining the appropriateness of therapy and the duration of treatment for patients. The objective is to identify the factors that influence the incidence of first molar caries.
Methods: This study employs an analytic case-control design with a retrospective cohort methodology. 161 RO TB patients and 161 SO TB patients comprised the total sample size. Statistical analysis of this investigation utilizing R and R Studio.
Result: In this study, there was a correlation between gender (p-value 0.006 and odds ratio 1.89), contact investigation (p-value 0.001 and odds ratio 0.23), new TB (p-value 0.001 and odds ratio 0.05), TB recurrence (p-value 0.001 and odds ratio 19.0), TB failed treatment (p-value 0.007 and odds ratio 16.4), and pH-saliva (p-value 0.0001 and odds ratio 21.250). In contrast, risk factors such as absenteeism, diabetes, and HIV were not associated with TB treatment status (p-value > 0.05). Age, investigation of contact, and TB recurrence were the predominant factors associated with TB treatment status, as determined by multivariate analysis.
Conclusions: Several factors, including gender and treatment history (new TB, Relapsed TB, Failed TB), influence the status of TB treatment in West Sumatra Province. These are important factors that must be considered and asked by TB officers at health facilities before the patient undergoes an examination of suspected samples and information to provide appropriate medical therapy to TB patients in health facilities.
References
Bawonte, T. G., Mambo, C. D. and Masengi, A. S. R. (2021) ‘Faktor-Faktor Yang Mempengaruhi Tuberculosis Multidrug Resistance (TB MDR)’, Jurnal e-Biomedik, 9(1), pp. 117–125. doi: 10.35790/ebm.v9i1.31949.
Damayanti, L., Widada, W. and Adi, S. (2022) ‘Status Pengobatan Berhubungan Dengan Kejadian Tuberkulosis Resistan Obat Pada Usia Produktif’, Profesional Health Journal, 3(2), pp. 138–148. Available at: https://www.ojsstikesbanyuwangi.com/index.php/PHJ.
Dinas Kesehatan Provinsi Sumatera Barat (2021) Laporan Audit Klinis Rumah Sakit Pelayanan TBC Resisten Obat.
Dirjen P2P Kemenkes RI (2020) ‘Protokol tata laksana pasien TBC dalam masa Pandemi Covid-19.’
DPPPA Kota Bogor. (2021) Apa Perbedaan Gender dan Jenis Kelamin ? Available at: https://dpppa.kotabogor.go.id/index.php/welcome/post/single/113.
Fitriani, N. I. (2020) ‘injauan pustaka covid-19: virologi, patogenesis, dan manifestasi klinis’, Jurnal Medika Malahayati, 4(3), pp. 1–8.
Global Tuberculosis Report 2020 (no date). Geneva: World Health Organization.
Hogan, A. B. et al. (2020) ‘Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study’, The Lancet Global Health. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license, 8(9), pp. e1132–e1141. doi: 10.1016/S2214-109X(20)30288-6.
Kemenkes RI (2016) ‘Buku petunjuk TB-HIV untuk Petugas’, p. 7.
Kementerian Kesehatan Republik Indonesia (2020) ‘Strategi Nasional Penanggulangan Tuberkulosis di Indonesia 2020- 2024’, Pertemuan Konsolidasi Nasional Penyusunan STRANAS TB, p. 135.
Kementrian Kesehatan RI (2016) Peraturan Menteri Kesehatan Republik Indonesia Nomor 67 Tahun 2016: Pedoman Penanggulangan Tuberkulosis.
Manggasa, D. D. and Suharto, D. N. (2022) ‘Riwayat Pengobatan dan Komorbid Diabetes Mellitus Berhubungan Dengan Kejadian Tuberkulosis Resisten Obat’, Poltekita : Jurnal Ilmu Kesehatan, 15(4), pp. 403–408. doi: 10.33860/jik.v15i4.659.
Muna, N. and Cahyati, W. H. (2019) ‘Determinan Kejadian Tuberkulosis pada Orang dengan HIV/AIDS’, Higeia Journal of Public Health, 3(2), pp. 168–178.
Nurdin, N. (2020) ‘Analisis faktor-faktor determinan Individu terhadap Tuberculosis Multidrug Resistant (TB MDR) di Provinsi Sumatera Selatan’, Jurnal Kesehatan Komunitas, 6(1), pp. 63–67. doi: 10.25311/keskom.vol6.iss1.385.
Nurmala, Q. P. and Habib, I. (2019) ‘Hubungan Riwayat Pengobatan Tuberkulosis Dengan Insidensi Multidrugs Resistant Tuberculosis (Mdr Tb)’, 38. Available at: http://repository.umy.ac.id/handle/123456789/33711.
Nurwanti and Wahyono, B. (2016) ‘Hubungan Antara Faktor Penjamu ( Host ) Dan Faktor Lingkungan ( Environment ) Dengan Kejadian Tuberkulosis Paru Kambuh ( Relaps ) Di Puskesmas Se-Kota Semarang’, Public Health Perspective Journal, 1(1), pp. 77–87.
Parmelia, M et all (2019) 'Faktor yang berhubungan dengan Kejadian Putus Obat Pada Pasien Tuberkulosis Paru di Puskesmas Denpasar' Jurnal Medika Udayana, Vol. 8 No 9, September, 2019
Rosdiana, D. (2017) ‘Tuberkulosis Paru Resisten Obat dengan Komorbiditas Diabetes Mellitus’, Jurnal Kesehatan Melayu, 1(1), p. 45. doi: 10.26891/jkm.v1i1.14.
